|
1.
|
GLOBOCAN 2008, All Cancers (excluding
non-melanoma skin cancer) Incidence and Mortality Worldwide.
Available: http://globocan.iarc.fr/factsheets/cancers/all.asp.
Accessed August 26, 2012.
|
|
2.
|
Cancer Statistics in Japan-2011.
Available: http://ganjoho.jp/public/statistics/backnumber/2011_jp.html.
Accessed August 26, 2012.
|
|
3.
|
Goseki N, Koike M and Yoshida M:
Histopathologic characteristics of early stage esophageal
carcinoma. A comparative study with gastric carcinoma. Cancer.
69:1088–1093. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Roth JA and Putnam JB Jr: Surgery for
cancer of the esophagus. Semin Oncol. 21:453–461. 1994.PubMed/NCBI
|
|
5.
|
Sugimachi K, Inokuchi K, Kuwano H, Kai H,
Okamura T and Okudaira Y: Patterns of recurrence after curative
resection for carcinoma of the thoracic part of the esophagus. Surg
Gynecol Obstet. 157:537–540. 1983.PubMed/NCBI
|
|
6.
|
Karl RC, Schreiber R, Boulware D, Baker S
and Coppola D: Factors affecting morbidity, mortality, and survival
in patients undergoing Ivor Lewis esophagogastrectomy. Ann Surg.
231:635–643. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Orringer MB, Marshall B and Iannettoni MD:
Transhiatal esophagectomy: clinical experience and refinements. Ann
Surg. 230:392–403. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Chu KM, Law SY, Fok M and Wong J: A
prospective randomized comparison of transhiatal and transthoracic
resection for lower-third esophageal carcinoma. Am J Surg.
174:320–324. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Lieberman MD, Shriver CD, Bleckner S and
Burt M: Carcinoma of the esophagus. Prognostic significance of
histologic type. J Thorac Cardiovasc Surg. 109:130–139. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Ellis FH Jr, Heatley GJ, Krasna MJ,
Williamson WA and Balogh K: Esophagogastrectomy for carcinoma of
the esophagus and cardia: a comparison of findings and results
after standard resection in three consecutive eight-year intervals
with improved staging criteria. J Thorac Cardiovasc Surg.
113:836–848. 1997.
|
|
11.
|
Isono K, Sato H and Nakayama K: Results of
a nationwide study on the three-field lymph node dissection of
esophageal cancer. Oncology. 48:411–420. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Ando N, Ozawa S, Kitagawa Y, Shinozawa Y
and Kitajima M: Improvement in the results of surgical treatment of
advanced squamous esophageal carcinoma during 15 consecutive years.
Ann Surgery. 232:225–232. 2000.PubMed/NCBI
|
|
13.
|
Altorki N and Skinner D: Should en bloc
esophagectomy be the standard of care for esophageal carcinoma? Ann
Surg. 234:581–587. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Lerut T, Nafteux P, Moons J, et al:
Three-field lymphadenectomy for carcinoma of the esophagus and
gastroesophageal junction in 174 R0 resections: impact on staging,
disease-free survival, and outcome: a plea for adaptation of TNM
classification in upper-half esophageal carcinoma. Ann Surg.
240:962–974. 2004. View Article : Google Scholar
|
|
15.
|
Lerut T, Coosemans W, Decker G, et al:
Extended surgery for cancer of the esophagus and gastroesophageal
junction. J Surg Res. 117:58–63. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Altorki NK, Girardi L and Skinner DB: En
bloc esophagectomy improves survival for stage III esophageal
cancer. J Thorac Cardiovasc Surg. 114:948–956. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Collard JM: Exclusive radical surgery for
esophageal adenocarcinoma. Cancer. 91:1098–1104. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Clark GW, Peters JH, Ireland AP, et al:
Nodal metastasis and sites of recurrence after en bloc
esophagectomy for adenocarcinoma. Ann Thorac Surg. 58:646–654.
1994. View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Chen G, Wang Z, Liu XY and Liu FY:
Recurrence pattern of squamous cell carcinoma in the middle
thoracic esophagus after modified Ivor-Lewis esophagectomy. World J
Surg. 31:1107–1114. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Nakagawa S, Kanda T, Kosugi S, Ohashi M,
Suzuki T and Hatakeyama K: Recurrence pattern of squamous cell
carcinoma of the thoracic esophagus after extended radical
esophagectomy with three-field lymphadenectomy. J Am Coll Surg.
198:205–211. 2004. View Article : Google Scholar
|
|
21.
|
Matsubara T, Ueda M, Takahashi T, Nakajima
T and Nishi M: Localization of recurrent disease after extended
lymph node dissection for carcinoma of the thoracic esophagus. J Am
Coll Surg. 182:340–346. 1996.PubMed/NCBI
|
|
22.
|
Bhansali MS, Fujita H, Kakegawa T, et al:
Pattern of recurrence after extended radical esophagectomy with
three-field lymph node dissection for squamous cell carcinoma in
the thoracic esophagus. World J Surg. 21:275–281. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Hulscher JB, van Sandick JW, Tijssen JG,
Obertop H and van Lanschot JJ: The recurrence pattern of esophageal
carcinoma after transhiatal resection. J Am Coll Surg. 191:143–148.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Kyriazanos ID, Tachibana M, Shibakita M,
et al: Pattern of recurrence after extended esophagectomy for
squamous cell carcinoma of the esophagus. Hepatogastroenterology.
50:115–120. 2003.PubMed/NCBI
|
|
25.
|
Mariette C, Balon JM, Piessen G, Fabre S,
Van Seuningen I and Triboulet JP: Pattern of recurrence following
complete resection of esophageal carcinoma and factors predictive
of recurrent disease. Cancer. 97:1616–1623. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
26.
|
Akiyama H, Tsurumaru M, Udagawa H and
Kajiyama Y: Radical lymph node dissection for cancer of the
thoracic esophagus. Ann Surg. 220:364–373. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
27.
|
Kato H, Watanabe H, Tachimori Y and Iizuka
T: Evaluation of neck lymph node dissection for thoracic esophageal
carcinoma. Ann Thorac Surg. 51:931–935. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
28.
|
Altorki N, Kent M, Ferrara C and Port J:
Three-field lymph node dissection for squamous cell and
adenocarcinoma of the esophagus. Ann Surg. 236:177–183. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
29.
|
Urba SG, Orringer MB, Perez-Tamayo C,
Bromberg J and Forastiere A: Concurrent preoperative chemotherapy
and radiation therapy in localized esophageal adenocarcinoma.
Cancer. 69:285–291. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
30.
|
Walsh TN, Noonan N, Hollywood D, Kelly A,
Keeling N and Hennessy TP: A comparison of multimodal therapy and
surgery for esophageal adenocarcinoma. N Engl J Med. 335:462–467.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
31.
|
Nygaard K, Hagen S, Hansen HS, et al:
Pre-operative radio-therapy prolongs survival in operable
esophageal carcinoma: a randomized, multicenter study of
pre-operative radiotherapy and chemotherapy. The second
Scandinavian trial in esophageal cancer. World J Surg.
16:1104–1110. 1992. View Article : Google Scholar
|
|
32.
|
Le Prise E, Etienne PL, Meunier B, et al:
A randomized study of chemotherapy, radiation therapy, and surgery
versus surgery for localized squamous cell carcinoma of the
esophagus. Cancer. 73:1779–1784. 1994.PubMed/NCBI
|
|
33.
|
Apinop C, Puttisak P and Preecha N: A
prospective study of combined therapy in esophageal cancer.
Hepatogastroenterology. 41:391–393. 1994.PubMed/NCBI
|
|
34.
|
Bosset JF, Gignoux M, Triboulet JP, et al:
Chemoradiotherapy followed by surgery compared with surgery alone
in squamous-cell cancer of the esophagus. N Engl J Med.
337:161–167. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
35.
|
Urba SG, Orringer MB, Turrisi A,
Iannettoni M, Forastiere A and Strawderman M: Randomized trial of
preoperative chemo-radiation versus surgery alone in patients with
locoregional esophageal carcinoma. J Clin Oncol. 19:305–313.
2001.PubMed/NCBI
|
|
36.
|
Lee JL, Park SI, Kim SB, et al: A single
institutional phase III trial of preoperative chemotherapy with
hyperfractionation radiotherapy plus surgery versus surgery alone
for resectable esophageal squamous cell carcinoma. Ann Oncol.
15:947–954. 2004. View Article : Google Scholar
|
|
37.
|
Burmeister BH, Smithers BM, Gebski V, et
al: Surgery alone versus chemoradiotherapy followed by surgery for
resectable cancer of the oesophagus: a randomised controlled phase
III trial. Lancet Oncol. 6:659–668. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
38.
|
Tepper J, Krasna MJ, Niedzwiecki D, et al:
Phase III trial of trimodality therapy with cisplatin,
fluorouracil, radiotherapy, and surgery compared with surgery alone
for esophageal cancer: CALGB 9781. J Clin Oncol. 26:1086–1092.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
39.
|
Fujiwara Y, Kamikonya N, Inoue T, et al:
Chemoradiotherapy for T3 and T4 squamous cell carcinoma of the
esophagus using low-dose FP and radiation: A preliminary report.
Oncol Rep. 14:1177–1182. 2005.PubMed/NCBI
|
|
40.
|
Fujiwara Y, Yoshikawa R, Kamikonya N, et
al: Trimodality therapy of esophagectomy plus neoadjuvant
chemoradiotherapy improves the survival of clinical stage II/III
esophageal squamous cell carcinoma patients. Oncol Rep. 28:446–452.
2012.
|
|
41.
|
Sobin LH and Wittekin CH: International
Union Against Cancer (UICC). TNM classification of malignant
tumors. 5th edition. John Wiley & Sons, Inc.; New York:
1997
|
|
42.
|
Japanese Society for Esophageal Diseases:
Guidelines for clinical and pathologic studies on carcinoma of the
esophagus. 9th edition. Kanehara & Co., Ltd.; Tokyo: 2001
|
|
43.
|
National Cancer Institute: Cancer Therapy
Evaluation Program, Common Terminology Criteria for Adverse Events.
Version 3.0. http://ctep.cancer.gov/protocolDevelopment/electronic_applications/docs/ctcaev3.pdf.
Accessed August 28, 2012.
|
|
44.
|
Muller JM, Erasmi H, Stelzner M, Zieren U
and Pichlmaier H: Surgical therapy of oesophageal carcinoma. Br J
Surg. 77:845–857. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
45.
|
Kakegawa T: Study on rational surgery for
thoracic esophageal cancer based on the esophageal lymphatic
drainage. Annual Report of the Cancer Research Ministry of Health
and Welfare 1990 Tokyo: National Cancer Center; pp. 285–289. 1991,
(In Japanese).
|
|
46.
|
Iizuka T: Report of 4th Meeting of ISDE
TNM. Research Committee; Kyoto. 1992
|
|
47.
|
Watanabe H, Kato H and Tachimori Y:
Significance of extended systemic lymph node dissection for
thoracic esophageal carcinoma in Japan. Recent Results Cancer Res.
155:123–133. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
48.
|
Ide H: Comprehensive Registry of
Esophageal Cancer in Japan (1998, 1999) and Long-term Results of
Esophagectomy in Japan (1988–1997). 3rd edition. The Japanese
Society for Esophageal Disease; Chiba: 2002
|
|
49.
|
Herskovic A, Martz K, al-Sarraf M, et al:
Combined chemotherapy and radiotherapy compared with radiotherapy
alone in patients with cancer of the esophagus. N Engl J Med.
326:1593–1598. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
50.
|
Minsky BD, Pajak TF, Ginsberg RJ, et al:
INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial
of combined-modality therapy for esophageal cancer: high-dose
versus standard-dose radiation therapy. J Clin Oncol. 20:1167–1174.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
51.
|
Yoshikawa R, Nakano Y, Tao L, et al:
Hedgehog signal activation in oesophageal cancer patients
undergoing neoadjuvant chemoradiotherapy. Br J Cancer.
98:1670–1674. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
52.
|
Igaki H, Tachimori Y and Kato H: Improved
survival for patients with upper and/or middle mediastinal lymph
node metastasis of squamous cell carcinoma of the lower thoracic
esophagus treated with 3-field dissection. Ann Surg. 239:483–490.
2004. View Article : Google Scholar
|
|
53.
|
Fujita H, Kakegawa T, Yamana H, et al:
Mortality and morbidity rates, postoperative course, quality of
life, and prognosis after extended radical lymphadenectomy for
esophageal cancer. Comparison of three-field lymphadenectomy with
two-field lymphadenectomy. Ann Surg. 222:654–662. 1995. View Article : Google Scholar
|
|
54.
|
Ando N, Kato H, Igaki H, et al: A
randomized trial comparing postoperative adjuvant chemotherapy with
cisplatin and 5-fluorouracil versus preoperative chemotherapy for
localized advanced squamous cell carcinoma of the thoracic
esophagus (JCOG9907). Ann Surg Oncol. 19:68–74. 2012. View Article : Google Scholar
|
|
55.
|
Kitagawa Y, Ando N, Nakamura K, Shibata T
and Fukuda H: The role of adjuvant chemotherapy for localized
squamous cell esophageal cancer: current Japanese standard and the
unending role of the drawing board. Ann Surg Oncol. 19:1425–1427.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
56.
|
Ajani JA and Swisher SG: Preoperative
chemotherapy for localized squamous cell carcinoma of the
esophagus? We should go back to the drawing board! Ann Surg Oncol.
19:3–4. 2012.PubMed/NCBI
|
